Neuromuscular Flashcards
Brachial Plexus Diagram

Trapezius
Nerve innovation
Action
CN XI, C3, C4.

Giant Axonal Neuropathy
Inheritance, age, nerve fiber type, Signs of neuropathy, gait, phenotype, pathognomonic pathology, mutation, prognosis.
rare autosomal recessive
manifests in early childhood
Intermediate filaments of CNS and PNS
Sensorimotor neuropathy (CST and UMN signs), predominately axonal
Optic atrophy leading to vision loss
Gait - walking on the inner edges of the feet
Tightly curled hair
Pathognomonic - large focal axonal swelling that contain tightly packed disorganized neurofilaments.
GAN gene mutation (encodes gigaxonin, involved in cross linking of intermediate filaments.
Progressive and death typically occurs by adolescence.
Refsum Disease
Inheritance, type of disorder, pathophysiology, general signs, Neurological signs, treatment
Autosomal dominant
Peroxisomal disorder
Enzyme defect -> involved in fatty acid metabolism - > accumulation of phytanic acid (an intermediate)
Retinitis pigmentosa (with night blindness and visual field constriction), Cardiomyopathy, Skin changes.
Neuropathy, hearing loss, anosmia, ataxia, and cerebellar signs.
Large-fiber sensorimotor neuropathy.
Overriding toes due to a shortened fourth metatarsal may aid in the diagnosis.
Treatment - Reduce dietary intake of phytanic acid.
MNGIE
Name, features, pathophysiology
myoneurogastrointestinal encephalopathy (MNGIE)
Features - Intestinal pseudoobstruction, ophthalmoparesis, demyelinating neuropathy.
Pathophysiology - Thymidine phosphorylase gene mutation
Abetalipoproteinemia
AKA, Inheritance, Pathophysiology, Dx (Labs), Clinical presentation
Bassen–Kornzweig syndrome
Autosomal recessive
Defective triglyceride transport -> abnormal very low-density lipoprotein secretion
Fat malabsorption -> vitamins A, E, D, and K deficiencies
Dx
Low levels of serum β-lipoprotein and vitamin E in the serum
Peripheral smear shows acanthocytes
Retinitis pigmentosa, neuropathy, and ataxia.
Mitochondrial cytopathy syndrome
Clinical presentation, pathophysiology
Other mitchondrial cytopathies
Neurogenic muscle weakness, ataxia, and retinitis pigmentosa syndrome
Adenosine triphosphate 6 gene mutation
Predominantly sensory axonal neuropathy
Other mitchondrial cytopathies
Mitochondrial encephalopathy with lactic acidosis and stroke-like symptoms (MELAS)
Disorders due to polymerase γ mutations
KSS
Pathophysiology, onset, clinical features
What is not a prominent feature?
Kearns–Sayre syndrome (KSS)
Mitochondrial DNA mutation
< 20 yo
Retinitis pigmentosa, progressive ophthalmoplegia, cardiac conduction defects, ataxia, myopathy, and hearing loss
Neuropathy is not a prominent feature of KSS.
Significant axon loss lesions
Reduce/increase action potential amplitudes?
Increased/preserved/mildly reduced conduction velocities?
Reductions in action potential amplitudes and tend to have preserved or mildly reduced conduction velocities
Define F-Wave on EMG
Where is it best obtained?
What is the F-wave always preceded by?
Long latency muscle action potential seen after supramaximal stimulation to a nerve.
Best obtained in the small foot and hand muscles.
F-wave is always preceded by a motor response and its amplitude is rather small, usually in the range of 0.2-0.5 mv.
The electrical impulse travels antidromically (conduction along the axon opposite to the normal direction of impulses) along the motor axons toward the motor neuron, backfiring and then traveling orthodromically (conduction along the motor axon in the normal direction) down the nerve to be recorded at the muscle.
3 main measures from NCS
- Sensory nerve action potential (SNAP) amplitude
- Sensory latency (onset and peak)
- Conduction velocity.
Define SNAP
SNAP amplitude (uV) = number of axons conducting between the stimulation site and the recording site.
Define Sensory Latency
Sensory latency (mS) = time it takes for the action potential to travel between the stimulation site and the recording site of the nerve.
Define conduction velocity
Conduction velocity is measured in meters per second and is obtained dividing the distance between stimulation site and the recording site by the latency: Conduction velocity = Distance/Latency.
How is a motor nerve conduction study obtained?
Define CMAP and what determines its response?
Stimulating a motor nerve and recording at the belly of a muscle innervated by that nerve.
Compound motor action potential
Depends on the motor axons transmitting the action potential, status of the neuromuscular junction, and muscle fibers.
What is routinely assessed and analyzed in a motor NCS?
Conduction velocity calculation and reason?
The CMAP amplitudes, motor onset latencies, and conduction velocities are routinely assessed and analyzed.
The distance between two stimulation sites is divided by the difference in onset latencies of those two sites, providing the conduction velocity in the segment of nerve between the two stimulation sites.
This avoids being confounded by time spent traversing the neuromuscular junction and triggering a muscle action potential (since these are subtracted out).
Correlations and associations for sensory and motor responses
Decrease in the amplitudes - >
Prolonged latencies
Slow conduction velocities
In general, for sensory and motor responses:
- Decrease in the amplitudes correlates with axon loss lesions. 2. Prolonged latencies and slow conduction velocities correlate with demyelination
- Low amplitudes can result from demyelinating conduction block when the nerve stimulation is proximal to the block.
Define H reflex
Site of stimulationa and recording
Direction of impulse travel
Why is the H-reflex test helpful?
The H-reflex is the electrophysiologic equivalent of the ankle reflex (S1 reflex arc)
Stimulate the tibial nerve at the popliteal fossa while recording at the soleus.
The electrical impulse travels orthodromically through a sensory afferent, enters the spinal cord, and synapses with the anterior horn cell, traveling down the motor nerve to be recorded at the muscle.
The H-reflex is the electrophysiologic equivalent of the ankle reflex, which is an S1 reflex, and this test is helpful in the evaluation of S1 radiculopathies.
When are large polyphasic motor unit potentials (MUPs) seen?
How is insertional activity recorded and when is it increased/decreased?
How is spontaneous activity assessed?
Chronic neuropathic lesions
Insertional activity is recorded as the needle is inserted into a relaxed muscle.
It is increased in denervated muscles and myotonic disorders, and is decreased when the muscle is replaced by fat or connective tissue and during episodes of periodic paralysis.
Spontaneous activity is assessed with the muscle at rest, and examples include fibrillation potentials, fasciculation potentials, and myokymia and myotonic potentials.
All spontaneous activity is abnormal.
Define:
Myokymia potential
Myotonia potential
Myokymia is a type of abnormal spontaneous electrical activity characterized by grouped discharges of motor unit action potentials. Myokymia originates from areas of axonal demyelination. The audio signal of myokymia is ‘marching.
Electrical myotonia is the spontaneous discharge of muscle fibers that waxes and wanes in both amplitude and frequency on electromyography (EMG). Myotonia is thought to be due to increased excitability of muscle fibers, leading to discharge of repetitive action potentials in response to stimulation.
How are MUPs obtained?
What is recruitment?
Describe what changes with MUPs in axon loss lesions or myopathic processes?
MUPs are obtained while the needle is inserted into the muscle during voluntary contraction.
Recruitment is a measure of the number of MUPs firing during increased force of voluntary muscle contraction.
In axon loss lesions, reduced recruitment is characterized by a less-than-expected number of MUPs firing more rapidly than expected.
Early or rapid recruitment occurs in myopathic processes with loss of muscle fibers, in which an excessive number of short-duration and small-amplitude MUPs fire during the muscle contraction.
MUPs in relation to neuropathic and myopathic disorders.
With poor voluntary effort or with CNS disorders causing weakness, recruitment is reduced with normal MUPs firing at slow or moderate rates, sometimes in a variable fashion.
In neuropathic disorders with denervation and reinnervation, MUPs disclose increased duration and amplitude, and may be polyphasic.
In myopathic disorders, MUPs are of reduced duration and amplitude, and may also be polyphasic.